InvestorsHub Logo
icon url

MinnieM

08/11/20 12:16 PM

#318244 RE: jav0033 #318186

Most, if not all, upcoming drugs will likely be tested against Remdesivir since it has approval to be used in covid patients.

https://www.gilead.com/purpose/advancing-global-health/covid-19

In the United States, the Food and Drug Administration (FDA) has authorized the emergency use of remdesivir to treat hospitalized adult and pediatric patients with suspected or laboratory confirmed SARS-CoV-2 infection and severe COVID-19. The FDA’s Emergency Use Authorization will enable appropriate patients more ready access to remdesivir at this time, due to the public health emergency. Remdesivir has not been approved by the FDA for any use, and the safety and efficacy of remdesivir for the treatment of COVID-19 are not yet established.



I look forward to Brilacidin entering a clinical trial in the near future since pr's have stated 4th quarter.





Message in reply to:

Has Leo confirmed any testing of Brilacidin and Remdesivir?
I don’t think so. PR from 7/20 did some comparisons but no combination of drugs.

Just keeping everyone with their feet on ground when bs speculation is written here.

Leronlimab might be the one being tested in conjunction with Remdesivir.